Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Sophia Claire 2025 Dec 05, 00:01

Trump's Fed Chair Pick: Power Plays and Monetary Policy in 2025

Noah Lee 2025 Dec 05, 00:00

Diverging Fed Rate Hike Expectations: Will the Fed Defy Forecasts?

Sophia Claire 2025 Dec 05, 00:00

PC Prices Projected to Surge by 2026 Amid AI-Driven Memory Shortage

Noah Lee 2025 Dec 05, 00:00

Gold Outlook 2026: Analyzing Scenarios and Potential Market Impacts

Noah Lee 2025 Dec 05, 00:00

Gold Nears Fair Value Amid Fed Uncertainty: Analyst Outlook

Ghko B 2025 Dec 04, 16:00

Bitcoin price prediction: BTC/USD rebounds, is BTC expected to rise further?

Ghko B 2025 Dec 04, 16:00

Nio stock price prediction: NIO jumps today, will this rally accelerate?

Ghko B 2025 Dec 03, 16:00

Stock opportunities for 2026: TSMC Stock, CRCL Stock, IONQ Stock, NIO

Ghko B 2025 Dec 03, 16:00

Best S&P 500 ETF to buy: Vanguard S&P 500 ETF (VOO), SPY, IVV, iShares ETFs

Ghko B 2025 Dec 03, 16:00

Best CFD Brokers: Award-winning CFD Platforms, markets.com, IG, Pepperstone

Latest news

Show more
Noah Lee 2025 Dec 05, 13:40

Beyond 'Buy the Dip': Institutional Crypto Investment Strategies

Noah Lee 2025 Dec 05, 13:10

The Future of Web3 Wallets: 5 Key Areas of Focus

Sophia Claire 2025 Dec 05, 12:50

Solana Presale Plagued by Bot Attack: WET Token Launch Scrapped

Noah Lee 2025 Dec 05, 12:20

Paribu Acquires CoinMENA: A Strategic Move into the MENA Crypto Market

Ava Grace 2025 Dec 05, 12:11

Aztec Network: Programmable Privacy as Ethereum Infrastructure

Liam James 2025 Dec 05, 12:00

China Associations Warn of Crypto and RWA Risks, Urge Vigilance

Sophia Claire 2025 Dec 05, 11:10

Layer-1 Cryptocurrencies vs. Bitcoin: A Market Dominance Analysis for 2026

Ava Grace 2025 Dec 05, 11:10

China Associations Warn Against Virtual Currency and Asset Tokenization Risks

Info

Spread

2.40

Spread (%)

0.7217 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

183169581056

Shares Outstanding

538480671

Earnings Date (Next)

1999-11-22

Div Yield

2025-12-12

Ex-Dividend Date

2025-11-21

Forward annual dividend rate

9.52

Forward annual dividend yield

0.0276

EPS

12.92

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Ghko B 2025 Dec 03, 16:00

What are the most traded indices: how to trade indices CFD with markets.com?

Ghko B 2025 Dec 03, 16:00

Start investing in 2026: trader's guide, how to find the best CFD broker?

Trustpilot